APO Research
Talk to an analyst

APO RESEARCH · REPORT

In-Vitro Cancer Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global In-Vitro Cancer Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchIn-Vitro Cancer Diagnostics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal In-Vitro Cancer Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal In-Vitro Cancer Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-Vitro Cancer Diagnostics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal In-Vitro Cancer Diagnostics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global In-Vitro Cancer Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for In-Vitro Cancer Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for In-Vitro Cancer Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In-Vitro Cancer Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for In-Vitro Cancer Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of In-Vitro Cancer Diagnostics include Abbott Laboratories, Beckman Coulter, Epigenomics AG, MDx Health Quest Diagnostics, Randox Laboratories, R-Biopharm AG, Signature Diagnostics, Amoy Diagnostics Co.,Ltd. and Daan Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global In-Vitro Cancer Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In-Vitro Cancer Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In-Vitro Cancer Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the In-Vitro Cancer Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

In-Vitro Cancer Diagnostics Segment by Company

Abbott Laboratories

Beckman Coulter

Epigenomics AG

MDx Health Quest Diagnostics

Randox Laboratories

R-Biopharm AG

Signature Diagnostics

Amoy Diagnostics Co.,Ltd.

Daan Gene

Fosun Pharma

Novogene

Burning Rock

Geneseeq

Siemens Healthcare

In-Vitro Cancer Diagnostics Segment by Type

Instruments

Reagents and Kits

In-Vitro Cancer Diagnostics Segment by Application

Laboratories

Hospitals

Others

In-Vitro Cancer Diagnostics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Cancer Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Cancer Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Cancer Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of In-Vitro Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In-Vitro Cancer Diagnostics industry.

Chapter 3: Detailed analysis of In-Vitro Cancer Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Cancer Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Instruments Table 3. Key Players of Reagents and Kits Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Laboratories Table 6. Key Players of Hospitals Table 7. Key Players of Others Table 8. Global In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global In-Vitro Cancer Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global In-Vitro Cancer Diagnostics Market Share by Region (2021-2026) Table 11. Global In-Vitro Cancer Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global In-Vitro Cancer Diagnostics Market Share by Region (2027-2032) Table 13. In-Vitro Cancer Diagnostics Industry Trends Table 14. In-Vitro Cancer Diagnostics Industry Drivers Table 15. In-Vitro Cancer Diagnostics Industry Opportunities and Challenges Table 16. In-Vitro Cancer Diagnostics Industry Restraints Table 17. Global In-Vitro Cancer Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global In-Vitro Cancer Diagnostics Revenue Market Share by Company (2021-2026) Table 19. Global In-Vitro Cancer Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global In-Vitro Cancer Diagnostics Key Company Head Office and Area Served Table 21. Global In-Vitro Cancer Diagnostics Company, Product Type & Application Table 22. Global In-Vitro Cancer Diagnostics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global In-Vitro Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global In-Vitro Cancer Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global In-Vitro Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global In-Vitro Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2021-2026) Table 29. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2027-2032) Table 30. Global In-Vitro Cancer Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global In-Vitro Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global In-Vitro Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2021-2026) Table 34. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2027-2032) Table 35. Abbott Laboratories Company Information Table 36. Abbott Laboratories Business Overview Table 37. Abbott Laboratories In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott Laboratories In-Vitro Cancer Diagnostics Product Portfolio Table 39. Abbott Laboratories Recent Development Table 40. Beckman Coulter Company Information Table 41. Beckman Coulter Business Overview Table 42. Beckman Coulter In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Beckman Coulter In-Vitro Cancer Diagnostics Product Portfolio Table 44. Beckman Coulter Recent Development Table 45. Epigenomics AG Company Information Table 46. Epigenomics AG Business Overview Table 47. Epigenomics AG In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Epigenomics AG In-Vitro Cancer Diagnostics Product Portfolio Table 49. Epigenomics AG Recent Development Table 50. MDx Health Quest Diagnostics Company Information Table 51. MDx Health Quest Diagnostics Business Overview Table 52. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product Portfolio Table 54. MDx Health Quest Diagnostics Recent Development Table 55. Randox Laboratories Company Information Table 56. Randox Laboratories Business Overview Table 57. Randox Laboratories In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Randox Laboratories In-Vitro Cancer Diagnostics Product Portfolio Table 59. Randox Laboratories Recent Development Table 60. R-Biopharm AG Company Information Table 61. R-Biopharm AG Business Overview Table 62. R-Biopharm AG In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. R-Biopharm AG In-Vitro Cancer Diagnostics Product Portfolio Table 64. R-Biopharm AG Recent Development Table 65. Signature Diagnostics Company Information Table 66. Signature Diagnostics Business Overview Table 67. Signature Diagnostics In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Signature Diagnostics In-Vitro Cancer Diagnostics Product Portfolio Table 69. Signature Diagnostics Recent Development Table 70. Amoy Diagnostics Co.,Ltd. Company Information Table 71. Amoy Diagnostics Co.,Ltd. Business Overview Table 72. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product Portfolio Table 74. Amoy Diagnostics Co.,Ltd. Recent Development Table 75. Daan Gene Company Information Table 76. Daan Gene Business Overview Table 77. Daan Gene In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Daan Gene In-Vitro Cancer Diagnostics Product Portfolio Table 79. Daan Gene Recent Development Table 80. Fosun Pharma Company Information Table 81. Fosun Pharma Business Overview Table 82. Fosun Pharma In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Fosun Pharma In-Vitro Cancer Diagnostics Product Portfolio Table 84. Fosun Pharma Recent Development Table 85. Novogene Company Information Table 86. Novogene Business Overview Table 87. Novogene In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Novogene In-Vitro Cancer Diagnostics Product Portfolio Table 89. Novogene Recent Development Table 90. Burning Rock Company Information Table 91. Burning Rock Business Overview Table 92. Burning Rock In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Burning Rock In-Vitro Cancer Diagnostics Product Portfolio Table 94. Burning Rock Recent Development Table 95. Geneseeq Company Information Table 96. Geneseeq Business Overview Table 97. Geneseeq In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Geneseeq In-Vitro Cancer Diagnostics Product Portfolio Table 99. Geneseeq Recent Development Table 100. Siemens Healthcare Company Information Table 101. Siemens Healthcare Business Overview Table 102. Siemens Healthcare In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Siemens Healthcare In-Vitro Cancer Diagnostics Product Portfolio Table 104. Siemens Healthcare Recent Development Table 105. North America In-Vitro Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 106. North America In-Vitro Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 107. North America In-Vitro Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 108. North America In-Vitro Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 109. North America In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) Table 111. North America In-Vitro Cancer Diagnostics Market Size by Country (2027-2032) Table 112. Europe In-Vitro Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe In-Vitro Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe In-Vitro Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe In-Vitro Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) Table 118. Europe In-Vitro Cancer Diagnostics Market Size by Country (2027-2032) Table 119. China In-Vitro Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 120. China In-Vitro Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 121. China In-Vitro Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 122. China In-Vitro Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia In-Vitro Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia In-Vitro Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia In-Vitro Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia In-Vitro Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) Table 129. Asia In-Vitro Cancer Diagnostics Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. In-Vitro Cancer Diagnostics Product Image Figure 2. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global In-Vitro Cancer Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. Instruments Image Figure 5. Reagents and Kits Image Figure 6. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global In-Vitro Cancer Diagnostics Market Share by Application: 2025 VS 2032 Figure 8. Laboratories Image Figure 9. Hospitals Image Figure 10. Others Image Figure 11. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global In-Vitro Cancer Diagnostics Market Share by Players in 2025 Figure 16. Global Top 5 and 10 In-Vitro Cancer Diagnostics Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global In-Vitro Cancer Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2021-2032) Figure 20. Global In-Vitro Cancer Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2021-2032) Figure 22. North America In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 23. North America In-Vitro Cancer Diagnostics Market Share by Type (2021-2032) Figure 24. North America In-Vitro Cancer Diagnostics Market Share by Application (2021-2032) Figure 25. North America In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 26. United States In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 27. Canada In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 28. Mexico In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 29. Europe In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 30. Europe In-Vitro Cancer Diagnostics Market Share by Type (2021-2032) Figure 31. Europe In-Vitro Cancer Diagnostics Market Share by Application (2021-2032) Figure 32. Europe In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 33. Germany In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 34. France In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 35. U.K. In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 36. Italy In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 37. Russia In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 39. China In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. China In-Vitro Cancer Diagnostics Market Share by Type (2021-2032) Figure 41. China In-Vitro Cancer Diagnostics Market Share by Application (2021-2032) Figure 42. Asia In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 43. Asia In-Vitro Cancer Diagnostics Market Share by Type (2021-2032) Figure 44. Asia In-Vitro Cancer Diagnostics Market Share by Application (2021-2032) Figure 45. Asia In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 46. Japan In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 47. South Korea In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 50. India In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 51. Australia In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 56. Brazil In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 57. South Africa In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 59. Turkey In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 60. Argentina In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 61. UAE In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 62. Egypt In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. Chile In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Reagents and Kits
Applications
  • Laboratories
  • Hospitals
  • Others
Companies covered
  • Abbott Laboratories
  • Beckman Coulter
  • Epigenomics AG
  • MDx Health Quest Diagnostics
  • Randox Laboratories
  • R-Biopharm AG
  • Signature Diagnostics
  • Amoy Diagnostics Co.,Ltd.
  • Daan Gene
  • Fosun Pharma
  • Novogene
  • Burning Rock
  • Geneseeq
  • Siemens Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Instruments
  5. 1.2.3 Reagents and Kits
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Laboratories
  9. 1.3.3 Hospitals
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global In-Vitro Cancer Diagnostics Growth Trends by Region
  13. 1.5.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 In-Vitro Cancer Diagnostics Market Size by Region (2021-2026)
  15. 1.5.3 In-Vitro Cancer Diagnostics Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global In-Vitro Cancer Diagnostics Market Dynamics
  1. 2.1 In-Vitro Cancer Diagnostics Industry Trends
  2. 2.2 In-Vitro Cancer Diagnostics Industry Drivers
  3. 2.3 In-Vitro Cancer Diagnostics Industry Opportunities and Challenges
  4. 2.4 In-Vitro Cancer Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global In-Vitro Cancer Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global In-Vitro Cancer Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global In-Vitro Cancer Diagnostics Key Company Head office and Area Served
  4. 3.4 Global In-Vitro Cancer Diagnostics Company, Product Type & Application
  5. 3.5 Global In-Vitro Cancer Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global In-Vitro Cancer Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 In-Vitro Cancer Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 In-Vitro Cancer Diagnostics Tier 1, Tier 2, and Tier 3
4 In-Vitro Cancer Diagnostics Market by Type
  1. 4.1 Global In-Vitro Cancer Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global In-Vitro Cancer Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global In-Vitro Cancer Diagnostics Market Size Share by Type (2021-2032)
5 In-Vitro Cancer Diagnostics Market by Application
  1. 5.1 Global In-Vitro Cancer Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global In-Vitro Cancer Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global In-Vitro Cancer Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott Laboratories In-Vitro Cancer Diagnostics Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Beckman Coulter
  8. 6.2.1 Beckman Coulter Company Information
  9. 6.2.2 Beckman Coulter Business Overview
  10. 6.2.3 Beckman Coulter In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Beckman Coulter In-Vitro Cancer Diagnostics Product Portfolio
  12. 6.2.5 Beckman Coulter Recent Developments
  13. 6.3 Epigenomics AG
  14. 6.3.1 Epigenomics AG Company Information
  15. 6.3.2 Epigenomics AG Business Overview
  16. 6.3.3 Epigenomics AG In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Epigenomics AG In-Vitro Cancer Diagnostics Product Portfolio
  18. 6.3.5 Epigenomics AG Recent Developments
  19. 6.4 MDx Health Quest Diagnostics
  20. 6.4.1 MDx Health Quest Diagnostics Company Information
  21. 6.4.2 MDx Health Quest Diagnostics Business Overview
  22. 6.4.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product Portfolio
  24. 6.4.5 MDx Health Quest Diagnostics Recent Developments
  25. 6.5 Randox Laboratories
  26. 6.5.1 Randox Laboratories Company Information
  27. 6.5.2 Randox Laboratories Business Overview
  28. 6.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Randox Laboratories In-Vitro Cancer Diagnostics Product Portfolio
  30. 6.5.5 Randox Laboratories Recent Developments
  31. 6.6 R-Biopharm AG
  32. 6.6.1 R-Biopharm AG Company Information
  33. 6.6.2 R-Biopharm AG Business Overview
  34. 6.6.3 R-Biopharm AG In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 R-Biopharm AG In-Vitro Cancer Diagnostics Product Portfolio
  36. 6.6.5 R-Biopharm AG Recent Developments
  37. 6.7 Signature Diagnostics
  38. 6.7.1 Signature Diagnostics Company Information
  39. 6.7.2 Signature Diagnostics Business Overview
  40. 6.7.3 Signature Diagnostics In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Signature Diagnostics In-Vitro Cancer Diagnostics Product Portfolio
  42. 6.7.5 Signature Diagnostics Recent Developments
  43. 6.8 Amoy Diagnostics Co.,Ltd.
  44. 6.8.1 Amoy Diagnostics Co.,Ltd. Company Information
  45. 6.8.2 Amoy Diagnostics Co.,Ltd. Business Overview
  46. 6.8.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product Portfolio
  48. 6.8.5 Amoy Diagnostics Co.,Ltd. Recent Developments
  49. 6.9 Daan Gene
  50. 6.9.1 Daan Gene Company Information
  51. 6.9.2 Daan Gene Business Overview
  52. 6.9.3 Daan Gene In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Daan Gene In-Vitro Cancer Diagnostics Product Portfolio
  54. 6.9.5 Daan Gene Recent Developments
  55. 6.10 Fosun Pharma
  56. 6.10.1 Fosun Pharma Company Information
  57. 6.10.2 Fosun Pharma Business Overview
  58. 6.10.3 Fosun Pharma In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Fosun Pharma In-Vitro Cancer Diagnostics Product Portfolio
  60. 6.10.5 Fosun Pharma Recent Developments
  61. 6.11 Novogene
  62. 6.11.1 Novogene Company Information
  63. 6.11.2 Novogene Business Overview
  64. 6.11.3 Novogene In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Novogene In-Vitro Cancer Diagnostics Product Portfolio
  66. 6.11.5 Novogene Recent Developments
  67. 6.12 Burning Rock
  68. 6.12.1 Burning Rock Company Information
  69. 6.12.2 Burning Rock Business Overview
  70. 6.12.3 Burning Rock In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Burning Rock In-Vitro Cancer Diagnostics Product Portfolio
  72. 6.12.5 Burning Rock Recent Developments
  73. 6.13 Geneseeq
  74. 6.13.1 Geneseeq Company Information
  75. 6.13.2 Geneseeq Business Overview
  76. 6.13.3 Geneseeq In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Geneseeq In-Vitro Cancer Diagnostics Product Portfolio
  78. 6.13.5 Geneseeq Recent Developments
  79. 6.14 Siemens Healthcare
  80. 6.14.1 Siemens Healthcare Company Information
  81. 6.14.2 Siemens Healthcare Business Overview
  82. 6.14.3 Siemens Healthcare In-Vitro Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Siemens Healthcare In-Vitro Cancer Diagnostics Product Portfolio
  84. 6.14.5 Siemens Healthcare Recent Developments
7 North America
  1. 7.1 North America In-Vitro Cancer Diagnostics Market Size (2021-2032)
  2. 7.2 North America In-Vitro Cancer Diagnostics Market Size by Type
  3. 7.2.1 North America In-Vitro Cancer Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America In-Vitro Cancer Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America In-Vitro Cancer Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America In-Vitro Cancer Diagnostics Market Size by Application
  7. 7.3.1 North America In-Vitro Cancer Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America In-Vitro Cancer Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America In-Vitro Cancer Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America In-Vitro Cancer Diagnostics Market Size by Country
  11. 7.4.1 North America In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America In-Vitro Cancer Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America In-Vitro Cancer Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe In-Vitro Cancer Diagnostics Market Size (2021-2032)
  2. 8.2 Europe In-Vitro Cancer Diagnostics Market Size by Type
  3. 8.2.1 Europe In-Vitro Cancer Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe In-Vitro Cancer Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe In-Vitro Cancer Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe In-Vitro Cancer Diagnostics Market Size by Application
  7. 8.3.1 Europe In-Vitro Cancer Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe In-Vitro Cancer Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe In-Vitro Cancer Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe In-Vitro Cancer Diagnostics Market Size by Country
  11. 8.4.1 Europe In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe In-Vitro Cancer Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe In-Vitro Cancer Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China In-Vitro Cancer Diagnostics Market Size (2021-2032)
  2. 9.2 China In-Vitro Cancer Diagnostics Market Size by Type
  3. 9.2.1 China In-Vitro Cancer Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China In-Vitro Cancer Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China In-Vitro Cancer Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China In-Vitro Cancer Diagnostics Market Size by Application
  7. 9.3.1 China In-Vitro Cancer Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China In-Vitro Cancer Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China In-Vitro Cancer Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia In-Vitro Cancer Diagnostics Market Size (2021-2032)
  2. 10.2 Asia In-Vitro Cancer Diagnostics Market Size by Type
  3. 10.2.1 Asia In-Vitro Cancer Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia In-Vitro Cancer Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia In-Vitro Cancer Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia In-Vitro Cancer Diagnostics Market Size by Application
  7. 10.3.1 Asia In-Vitro Cancer Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia In-Vitro Cancer Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia In-Vitro Cancer Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia In-Vitro Cancer Diagnostics Market Size by Country
  11. 10.4.1 Asia In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia In-Vitro Cancer Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia In-Vitro Cancer Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst